VABYSMO

Hoffmann-La Roche Limited🇨🇦 Health Canada

Approval Id: e16b3affa393ce06
Drug Approval Canada Name: VABYSMO
Product Name: VABYSMO
Status: Marketed
Status Date: 2022-07-18
Original Market Date: 2022-07-18
Din: 02527618
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravitreal
Schedule: Schedule D , Prescription
Ahfs: 52:92.00
Atc Original: S01LA09 FARICIMAB
Atc Name: s 01 la 09
Aig Number: 0163722001
Company Name: Hoffmann-La Roche Limited
Company Address: 7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8

FARICIMAB

6 MG / 0.05 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

e16b3affa393ce06

Type

Standard